Skip to main content

enVVeno Medical Corp

NVNO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001661053

In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding enVVeno Medical Corp changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of NVNO: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders1624+8
Shares841.9K2.08M+1.24M (+147.2%)
Value$8.74M$13.7M+$4.97M (+56.9%)

New holders (11)

Institutions that held enVVeno Medical Corp at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to NVNO in Q4 2021
InstitutionSharesValue% of portfolio
Perceptive Advisors LLC781,615$5.15M0.08%
Kingdon Capital Management, L.L.C.219,180$1.44M0.22%
Two Sigma Advisers, LP80,900$533.0K0.00%
Geode Capital Management, LLC80,045$527.0K0.00%
Velan Capital Investment Management LP74,478$491.0K0.41%
Two Sigma Investments, LP67,304$444.0K0.00%
Kepos Capital LP50,000$330.0K0.03%
Renaissance Technologies LLC14,300$94.0K0.00%
Arthur M. Cohen & Associates, LLC14,000$92.0K0.02%
PEAK6 Investments LLC1,797$12.0K0.00%
Tower Research Capital LLC (TRC)786$5.00K0.00%

Sold out (3)

Institutions that held enVVeno Medical Corp at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of NVNO in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
L & S Advisors Inc30,000$311.0K
Susquehanna Fundamental Investments, LLC15,842$164.0K
Marshall Wace, LLP12,207$127.0K